Vertex Pharmaceuticals Incorpor vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
8.4
Buy
Overall
6.2
Hold
Quality
Health
Growth
Valuation
Sentiment
VRTX
High-quality business with 23% return on equity and 33% profit margins.
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $548.39 (+28.0%)
28 analysts
BUY
Target $387.27 (+4.9%)
26 analysts
Fundamentals
VRTX
UNH
28.0×
Trailing P/E
27.9×
19.7×
Forward P/E
17.8×
32.9%
Profit Margin
2.7%
53.7%
Gross Margin
18.8%
22.5%
ROE
12.2%
9.5%
Revenue Growth
2.0%
32.9%
Earnings Growth
0.7%
0.37
Beta
0.41
—
Price / Book
—
$109.0B
Market Cap
$335.3B
$363 – $509
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.